These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10290517)

  • 61. Assessing new technology: CEDIT.
    Jolly D
    World Hosp; 1985 Nov; 21(4):45-6. PubMed ID: 10276037
    [No Abstract]   [Full Text] [Related]  

  • 62. Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?
    Mott DJ
    Patient; 2018 Jun; 11(3):249-252. PubMed ID: 29500706
    [No Abstract]   [Full Text] [Related]  

  • 63. Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries.
    Levy AR; Garrison LP
    Value Health; 2010 Jun; 13 Suppl 1():S1-3. PubMed ID: 20618787
    [No Abstract]   [Full Text] [Related]  

  • 64. Introduction. Bayesian approaches to technology assessment and decision making.
    Luce BR; Shih YC; Claxton K
    Int J Technol Assess Health Care; 2001; 17(1):1-5. PubMed ID: 11329837
    [No Abstract]   [Full Text] [Related]  

  • 65. Go/no go on new clinical technology. What to consider when assessing its implementation in the group practice.
    Leigh JE
    MGMA Connex; 2002 Sep; 2(8):30-1. PubMed ID: 12235998
    [No Abstract]   [Full Text] [Related]  

  • 66. Vox populi and public policy: why should we care?
    Miller HI
    Nat Biotechnol; 2003 Dec; 21(12):1431-2. PubMed ID: 14647319
    [No Abstract]   [Full Text] [Related]  

  • 67. Technology assessment: differing perspectives.
    Cahill N; Beljan J
    JAMA; 1984 Dec; 252(23):3294-5. PubMed ID: 6439898
    [No Abstract]   [Full Text] [Related]  

  • 68. Features to consider when selecting new ultrasound imaging systems.
    Hangiandreou NJ; Stekel SF; Tradup DJ
    J Am Coll Radiol; 2011 Jul; 8(7):521-3. PubMed ID: 21723494
    [No Abstract]   [Full Text] [Related]  

  • 69. Technology assessment: one view from American medicine.
    Cahill NE
    Int J Technol Assess Health Care; 1985; 1(3):693-702. PubMed ID: 10276736
    [No Abstract]   [Full Text] [Related]  

  • 70. Technological assessment.
    Barclay WR
    JAMA; 1981 Jun; 245(24):2519. PubMed ID: 7230492
    [No Abstract]   [Full Text] [Related]  

  • 71. Problems in assessing technology.
    Vatz J
    Tecnologica; 1995 Sep; ():10. PubMed ID: 10168300
    [No Abstract]   [Full Text] [Related]  

  • 72. A protocol approach to assessing medical technologies.
    Lasch K; Maltz A; Mosteller F; Tosteson T
    Int J Technol Assess Health Care; 1987; 3(1):103-22. PubMed ID: 10282215
    [No Abstract]   [Full Text] [Related]  

  • 73. Legislation expands federal role in medical technology assessment.
    Marwick C
    JAMA; 1984 Dec; 252(23):3235-7. PubMed ID: 6512921
    [No Abstract]   [Full Text] [Related]  

  • 74. Diagnostic and therapeutic technology assessment. Chelation therapy.
    JAMA; 1983 Aug; 250(5):672. PubMed ID: 6663679
    [No Abstract]   [Full Text] [Related]  

  • 75. Diagnostic and therapeutic technology assessment. Implantable infusion pump.
    JAMA; 1983 Oct; 250(14):1906. PubMed ID: 6663675
    [No Abstract]   [Full Text] [Related]  

  • 76. Diagnostic and therapeutic technology assessment. Garren gastric bubble.
    JAMA; 1986 Dec; 256(23):3282-4. PubMed ID: 3783875
    [No Abstract]   [Full Text] [Related]  

  • 77. ACP reps testify on technology assessment.
    Am Coll Physicians Obs; 1981 May; 1(5):1, 3. PubMed ID: 10254020
    [No Abstract]   [Full Text] [Related]  

  • 78. American Medical Association Education and Research Foundation unveils new Institute for Biomedical Research.
    J Med Assoc Ga; 1966 Nov; 54(11):375-6. PubMed ID: 5978381
    [No Abstract]   [Full Text] [Related]  

  • 79. Diagnostic and therapeutic technology assessment. Diathermy.
    JAMA; 1983 Jul; 250(4):540. PubMed ID: 6668647
    [No Abstract]   [Full Text] [Related]  

  • 80. Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines.
    Ghabri S; Cleemput I; Josselin JM
    Pharmacoeconomics; 2018 Feb; 36(2):127-130. PubMed ID: 29264865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.